SITE001-0119

SITE001 (USA) › SITE001-0119

SITE001-0119

A Phase III, Randomized, Double-Blind Study of Torivumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Previously Untreated Advanced Non-Small Cell Lung Cancer · Phase III
SITE001 (USA) · Dr. Reyes
consented 2026-01-26

enrolled

AEs

4

Serious

1

Dropout signal

–

Adverse events

4

Grade 4 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2023-03-09 (study day 221); relationship: NOT RELATED; serious criteria: life-threatening

severe serious under_review

Grade 1 Fatigue — outcome: RECOVERED/RESOLVED; onset 2022-12-19 (study day 141); relationship: NOT RELATED

mild assessed

Grade 1 Diarrhoea — outcome: RECOVERED/RESOLVED; onset 2022-12-02 (study day 124); relationship: not assessed

mild assessed

Grade 1 Neutropenia — outcome: RECOVERED/RESOLVED; onset 2022-09-08 (study day 39); relationship: not assessed

mild assessed

Data queries

0

No data queries. Open queries would appear here for this patient.